http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11419863-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1cec86f42cf1ac5bfc2a70b6e8b82415
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2017-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a8e0337b0e04f6e06f6ccc23b7c6643
publicationDate 2022-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-11419863-B2
titleOfInvention Composition containing apomorphine and a divalent metal cation
abstract A composition containing apomorphine and a divalent metal cation, such as, for example, Zn2+, Ca2+, or Mg2+, is disclosed. The composition contains apomorphine and the divalent metal cation in a molar ratio of 2 or less. Optionally, the composition contains an antioxidant. The composition can be prepared as a medicament for treating Parkinson's disease.
priorityDate 2014-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014128422-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011111101-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009143474-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017055337-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011111011-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6514482-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003225031-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2545905-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012220544-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452148459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454002584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448339016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25058166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23662354
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399716
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399704

Total number of triples: 58.